000 01784 a2200577 4500
005 20250517145911.0
264 0 _c20180727
008 201807s 0 0 eng d
022 _a1468-3288
024 7 _a10.1136/gutjnl-2016-312869
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHanin, Geula
245 0 0 _amiRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression.
_h[electronic resource]
260 _bGut
_c06 2018
300 _a1124-1134 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAnimals
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHyperlipidemias
_xdrug therapy
650 0 4 _aLipids
_xblood
650 0 4 _aLipogenesis
_xdrug effects
650 0 4 _aLiver
_xmetabolism
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Obese
650 0 4 _aMice, Transgenic
650 0 4 _aMicroRNAs
_xantagonists & inhibitors
650 0 4 _aMiddle Aged
650 0 4 _aNon-alcoholic Fatty Liver Disease
_xdrug therapy
650 0 4 _aOligonucleotides, Antisense
_xpharmacology
700 1 _aYayon, Nadav
700 1 _aTzur, Yonat
700 1 _aHaviv, Rotem
700 1 _aBennett, Estelle R
700 1 _aUdi, Shiran
700 1 _aKrishnamoorthy, Yoganathan R
700 1 _aKotsiliti, Eleni
700 1 _aZangen, Rivka
700 1 _aEfron, Ben
700 1 _aTam, Joseph
700 1 _aPappo, Orit
700 1 _aShteyer, Eyal
700 1 _aPikarsky, Eli
700 1 _aHeikenwalder, Mathias
700 1 _aGreenberg, David S
700 1 _aSoreq, Hermona
773 0 _tGut
_gvol. 67
_gno. 6
_gp. 1124-1134
856 4 0 _uhttps://doi.org/10.1136/gutjnl-2016-312869
_zAvailable from publisher's website
999 _c27053700
_d27053700